Skip to content

XIAMEN SPACEGEN CO.,LTD.

China CN-MF-000018018 Last updated 8 Jun 2026

Is this your brand? Sign in to claim this brand

Devices
37
Registries
EUDAMED
FDA recalls
0

Catalogue37

Authorised representatives

What XIAMEN SPACEGEN CO.,LTD. makes

The company manufactures in vitro diagnostic (IVD) kits for detecting specific gene mutations and viral antigens. Products include high-throughput sequencing and multiplex PCR-based assays for BRCA1/2, K-ras, EGFR, BCR-ABL, and other oncogenic mutations, as well as a rapid antigen test for SARS-CoV-2. Additional kits target colorectal cancer-related genes, MGMT methylation, and gene fusions like ALK, ROS1, RET, and NTRK.

These diagnostic devices fall under the IVD General category and are registered in the EU’s eudamed database. The manufacturer is based in China.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Xiamen Spacegen Co., Ltd. manufacture?

Xiamen Spacegen Co., Ltd. specializes in in vitro diagnostic (IVD) kits designed for detecting specific gene mutations and viral antigens. Their portfolio includes high-throughput sequencing assays for oncogenic mutations like BRCA1/2, EGFR, and K-ras, as well as multiplex PCR-based kits for detecting mutations in genes such as BCR-ABL and MGMT methylation. They also produce a rapid antigen test for detecting SARS-CoV-2 using colloidal gold technology. These devices are primarily used in oncology, virology, and cancer-related diagnostics.

Where is Xiamen Spacegen Co., Ltd. based?

Xiamen Spacegen Co., Ltd. is headquartered in China. The company’s location influences its regulatory compliance requirements, particularly for devices intended for international markets like the European Union.

Which regulatory registries list Xiamen Spacegen Co., Ltd.’s devices?

Xiamen Spacegen Co., Ltd.’s devices are listed in the eudamed database, which is the European Union’s central registry for medical devices. This registry is used to track manufacturers, devices, and their regulatory status within the EU market. Listing in eudamed is a requirement for devices placed on the EU market under regulations like IVDR (In Vitro Diagnostic Regulation).

How are Xiamen Spacegen Co., Ltd.’s devices classified?

Xiamen Spacegen Co., Ltd.’s devices fall under the IVD General classification. This classification applies to most in vitro diagnostic tests, including gene mutation detection kits and antigen tests, as they are intended for general diagnostic use rather than high-risk applications like invasive procedures or implantable devices. Classification determines regulatory pathways, such as conformity assessment procedures, but does not imply approval—only individual devices undergo authorization processes.

What is the primary purpose of Xiamen Spacegen Co., Ltd.’s diagnostic kits?

The primary purpose of Xiamen Spacegen Co., Ltd.’s diagnostic kits is to detect specific genetic mutations and viral antigens for clinical decision-making. For example, their BRCA1/2 and EGFR mutation detection kits support personalized cancer treatment by identifying genetic markers associated with tumor behavior, while their SARS-CoV-2 antigen test aids in rapid infection screening. These kits are designed to assist healthcare providers in diagnosing, monitoring, or managing diseases like cancer and infectious conditions.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
China
Address
Room 401 of 4th floor of No.2041, 7th floor of No.2043, 4th floor of No.2045, Xizhou Road, Xike Town, Tong’an District, Xiamen, China
Website
ispacegen.com
PRRC contact
Feifei Guo
EUDAMED SRN
CN-MF-000018018